Clustering data with hclust algorithm for Effects of dietary supplement on hamster metabolism (Study ST000344)

RP POSITIVE ION MODE (Analysis AN000557)
MetaboliteStructureF1F2
PE (36:2)ME1187360.871.13
1_TG (17:0/17:1/17:0)-d5 iSTDME1187071.260.74
Ceramide (d42:1)ME1187091.280.72
Ceramide (d40:1)ME1187081.290.71
PC (p-34:3) or PC (o-34:4)ME1187281.290.71
SM (d40:0)ME1187421.300.70
SM (d42:0)ME1187431.310.69
1_DG (12:0/12:0/0:0) iSTDME1186941.370.63
1_DG (18:1/2:0/0:0) iSTDME1186961.330.67
PC (42:1)ME1187261.120.88
PC (40:1)ME1187241.120.88
1_LPE (17:1) iSTDME1186981.120.88
1_MG (17:0/0:0/0:0) iSTDME1187011.120.88
PE (34:2)ME1187341.130.87
1_PE (17:0/17:0) iSTDME1187031.130.87
PC (p-36:3) or PC (o-36:4)ME1187311.130.87
SM (d34:0)ME1187411.140.86
PE (34:1)ME1187331.140.86
PC (p-36:0) or PC (o-36:1)ME1187291.140.86
PC (32:1)ME1187191.140.86
PC (30:0)ME1187171.140.86
1_Cholesterol d7 iSTDME1186911.140.86
Lactosylceramide (d18:1/24:1(15Z))ME1187151.140.86
PC (36:1)ME1187211.150.85
1_Sphingosine (d17:1) iSTDME1187051.150.85
PC (32:3)ME1187201.150.85
GlcCer (d40:1)ME1187121.200.80
PC (28:0)ME1187161.210.79
PE (p-32:1) oe PE (o-32:2)ME1187371.210.79
PE (36:1)ME1187351.190.81
GlcCer (d42:1)ME1187131.180.82
PE (p-36:1) or PE (o-36:2)ME1187391.180.82
PC (30:1)ME1187181.170.83
1_SM (d35:1) iSTDME1187041.170.83
1_LPC (17:0) iSTDME1186971.170.83
1_PC (25:0) iSTDME1187021.170.83
PE (p-34:1) or PE (o-34:2)ME1187381.160.84
Ceramide (d42:2)ME1187101.160.84
PE (32:1)ME1187321.160.84
PC (38:4) BME1187231.100.90
1_Ceramide C17 iSTDME1186901.090.91
Gal-Gal-Cer(d18:1/16:0) or Lactosylceramide(d18:1/16:0)ME1187111.080.92
PE (p-36:2) or PE (o-36:3)ME1187401.060.94
PC (40:2)ME1187251.030.97
1_CE (22:1) iSTDME1186871.050.95
1_CUDA (pos) iSTDME1186921.040.96
PC (42:2)ME1187271.040.96
PC (38:2)ME1187220.991.01
GlcCer (d42:2)ME1187141.010.99
PC (p-36:1) or PC (o-36:2)ME1187301.010.99

Factors:

F1Treatment:Control
F2Treatment:Lipid Supplement
Data matrix
  logo